Is Sesame Lipid Profile Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Sesame Lipid Profile Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - This comprehensive systematic review and meta-analysis aimed to assess the impact of sesame (Sesamum indicum L.) supplementation on cardiovascular disease risk factors. [Jafari A (2025); evidence level 1] - The assessment of study quality was conducted using the Cochrane risk-of-bias tool. [Jafari A (2025); evidence level 1] - Subgroup analyses revealed that sesame supplementation significantly reduced CRP and malondialdehyde (MDA) in populations without chronic diseases, while total cholesterol (TC) and MDA were reduced in those with chronic diseases. [Jafari A (2025); evidence level 1] - Relevant research was discovered via PubMed, Scopus, Web of Science, CENTRAL, and EMBASE up to June 2024. [Jafari A (2025); evidence level 1] - Diabetes mellitus and dyslipidemia are significant health concerns that elevate the risk of cardiovascular disease and other metabolic disorders, necessitating effective management strategies. [Fornari Laurindo L (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.